Following Patients with Geographic Atrophy (GA)

Jun 9, 2024

Tips for Following Patients with Geographic Atrophy (GA)

Speaker: Retina Specialist at the I Clinic of Wisconsin

Key Points

  1. Visual Acuity vs. Visual Function

    • Visual acuity does not equate to visual function.
    • Significant disease progression can occur before a decrease in visual acuity is noticed.
    • Utilize ancillary imaging tools like OCT and fundus fluorescence to track patients.
  2. Location of Lesions

    • Non-subfoveal lesions are more aggressive and spread more rapidly than subfoveal lesions.
    • The location of lesions can influence follow-up schedules and treatment plans.
  3. Status of the Fellow Eye

    • The condition of the fellow eye impacts treatment motivation and compliance.
    • Important for both the patient and the treating physician to consider.
  4. Setting Appropriate Expectations for Treatment

    • GA treatments will not improve vision but slow disease progression.
    • Use the analogy of jumping out of an airplane: GA treatments are like deploying a parachute, slowing the fall rather than stopping it.

Rationale for Offering GA Treatments

  • Unmet Need: There's a significant unmet need in treating GA.
  • Hope and Science: Treatments represent hope as much as they do scientific advancement.
  • Split Among Retina Specialists: Not all specialists offer GA treatments, but the speaker does due to the above reasons.